Related Experiment Videos
Genomic testing for sensitivity of breast cancer to hormonal therapy
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Circulating tumor DNA concentration at diagnosis is a modifiable prognostic factor for distant metastatic recurrence in patients with high-risk breast cancer receiving neoadjuvant therapy.
medRxiv : the preprint server for health sciences·2026
Prediction of benefit from docetaxel chemotherapy for HR-positive breast cancer in the PACS-01 trial.
Breast (Edinburgh, Scotland)·2026
Stage-related transcriptional changes in HR-positive/HER2-negative breast cancer.
NPJ breast cancer·2026
Sensitivity to Endocrine Therapy Index Predicts Benefit from Weekly Adjuvant Paclitaxel for Hormone Receptor-Positive Breast Cancer in the GEICAM/9906 Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer Recurrence.
medRxiv : the preprint server for health sciences·2026
KRAS Q61 NSCLC: When Alleles Matter.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Response-Adapted Surgery after Neoadjuvant Immunochemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma (REMATCH): A Single-Arm Phase II Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Associations of Baseline Neutrophil-to-Lymphocyte Ratio with Efficacy and Toxicity of the B7H3 ADC YL201, Linked to Interleukin-6: Analysis of the Phase 1/1b Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Ceralasertib plus durvalumab in Ras mutant and Ras wild type advanced non-small cell lung cancer: Two cohorts of the phase II platform National Lung Matrix Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Neoadjuvant Pertuzumab Biosimilar HLX11 Versus Reference Pertuzumab for Early-stage or Locally Advanced Breast Cancer: A phase 3 Equivalence Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026